Logo Logo

Publications by Michl, M.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 8.

Journal article

Holch, J. W.; Ricard, I.; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Heintges, T.; Kahl, C.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Jelas, I.; Modest, D. P.; Westphalen, C. B.; Einem, J. C. von; Michl, M.; Heinemann, V. (2018): Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). In: European Journal of Cancer, Vol. 106: pp. 115-125

Michl, M.; Michl, G. M. (2017): Kopfschmerzen. In: Internist, Vol. 58, No. 9: pp. 892-899

Michl, M.; Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S.-E.; Heintges, T.; Lerchenmüller, C.; Kahl, C.; Seipelt, G.; Kullmann, F.; Stauch, M.; Scheithauer, W.; Hielscher, J.; Scholz, M.; Mueller, S.; Lerch, M. M.; Modest, D. P.; Kirchner, T.; Jung, A.; Heinemann, V. (2016): CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)(aEuro). In: Annals of Oncology, Vol. 27, No. 8: pp. 1565-1572

Michl, M.; Heinemann, V.; Jung, A.; Engel, Jutta; Kirchner, T.; Neumann, J. (2015): Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system. In: Pathology, Research and Practice, Vol. 211, No. 8: pp. 601-609

Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta; Heinemann, V. (2015): Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors. In: Clinical Colorectal Cancer, Vol. 14, No. 4: pp. 281-290

Heinemann, V.; Stintzing, S.; Modest, D. P.; Giessen-Jung, C.; Michl, M.; Mansmann, Ulrich (2015): Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC). In: European Journal of Cancer, Vol. 51, No. 14: pp. 1927-1936

Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, P.; Hoffmann, R. T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Heinemann, V. (2014): Radioembolization with Yttrium-90 Microspheres (SIRT) in Pancreatic Cancer Patients with Liver Metastases: Efficacy, Safety and Prognostic Factors. In: Oncology, Vol. 86, No. 1: pp. 24-32

Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, Philipp M.; Hoffmann, R.-T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, R. P.; Heinemann, V. (2014): Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: Efficacy, safety and prognostic factors. In: Oncology, Vol. 86, No. 1: pp. 24-32 [PDF, 265kB]

This list was generated on Tue Aug 11 01:56:58 2020 CEST.